Nvidia says it's evaluating a 'variety of products' after report of new AI China chip

Nvidia is developing a new AI chip for China, the Blackwell-based B30A, reportedly more powerful than the currently permitted H20 model but designed to navigate U.S. export controls, with samples expected as early as next month. This initiative, alongside the forthcoming inference-focused RTX6000D chip, underscores Nvidia's strategic imperative to retain market share in China—a critical 13% revenue source—amidst persistent U.S. regulatory uncertainty regarding advanced chip sales and intensifying U.S.-Sino tech tensions, while also facing rising domestic competition.

Analysis

Nvidia is proactively navigating U.S. export controls by developing two new AI chips for the Chinese market based on its latest Blackwell architecture. The B30A is designed as a more powerful successor to the current H20 model, while the RTX6000D is a lower-specification inference chip engineered to fall just below specific regulatory thresholds, such as its memory bandwidth of 1,398 GB/s. This dual-product strategy underscores a critical effort to protect its market share in China, a region that constituted 13% of its revenue in the past fiscal year, and to prevent customers from migrating to competitors like Huawei. However, this initiative is fraught with significant regulatory uncertainty, as reflected by the negative per-ticker sentiment score (-0.3) and the volatile history of U.S. approvals for China-specific chips. While recent political comments suggest a potential opening for scaled-down chip sales, deep-seated bipartisan concerns in Washington make any future approvals far from guaranteed, creating a high-risk, high-reward scenario for Nvidia's China operations.

Key Decisions for Investors

• Investors should closely monitor communications from the U.S. Department of Commerce and political developments, as regulatory approvals for the new B30A and RTX6000D chips are the primary catalyst and risk factor for Nvidia's China revenue stream.
• The 13% revenue exposure to China should be treated as highly volatile; a key metric to watch will be the adoption rate of these new chips versus domestic alternatives from competitors like Huawei.
• Given the significant geopolitical uncertainty and the abrupt policy shifts previously seen with the H20 chip, it may be prudent to assess position sizing or consider hedging strategies to mitigate potential negative impacts from U.S.-Sino trade tensions.